101 related articles for article (PubMed ID: 15023165)
21. Examination of serum pepsinogen in functional dyspepsia.
Tahara T; Shibata T; Okubo M; Yamashita H; Yoshioka D; Yonemura J; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Yamada H; Nakamura M; Arisawa T; Hirata I
Hepatogastroenterology; 2012; 59(120):2516-22. PubMed ID: 23178618
[TBL] [Abstract][Full Text] [Related]
22. Effect of Helicobacter pylori eradication therapy on risk of hospitalization for a major ulcer event.
Hsiao FY; Tsai YW; Wen YW; Kuo KN; Tsai CR; Huang WF
Pharmacotherapy; 2011 Mar; 31(3):239-47. PubMed ID: 21361733
[TBL] [Abstract][Full Text] [Related]
23. Functional dyspepsia: new insights into pathogenesis and therapy.
Talley NJ
Korean J Intern Med; 2016 May; 31(3):444-56. PubMed ID: 27048251
[TBL] [Abstract][Full Text] [Related]
24. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
[TBL] [Abstract][Full Text] [Related]
25. Histamine H2 antagonists for functional dyspepsia: A protocol for a systematic review and meta-analysis.
Li J; Wang F; Lv L; Xu L; Zeng E; Tang X
Medicine (Baltimore); 2019 Nov; 98(47):e18128. PubMed ID: 31764854
[TBL] [Abstract][Full Text] [Related]
26. Controlled trial of interventions to increase testing and treatment for Helicobacter pylori and reduce medication use in patients with chronic acid-related symptoms.
Majumdar SR; Ross-Degnan D; Farraye FA; Lee M; Kemp JA; Lecates RF; Henning JM; Tunis SR; Schrammel P; Soumerai SB
Aliment Pharmacol Ther; 2005 Apr; 21(8):1029-39. PubMed ID: 15813839
[TBL] [Abstract][Full Text] [Related]
27. Helicobacter pylori eradication versus prokinetics in the treatment of functional dyspepsia: a randomized, double-blind study.
Ang TL; Fock KM; Teo EK; Chan YH; Ng TM; Chua TS; Tan JY
J Gastroenterol; 2006 Jul; 41(7):647-53. PubMed ID: 16933001
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.
Gisbert JP; Khorrami S; Carballo F; Calvet X; Gene E; Dominguez-Muñoz E
Aliment Pharmacol Ther; 2004 Mar; 19(6):617-29. PubMed ID: 15023164
[TBL] [Abstract][Full Text] [Related]
29. Role of Helicobacter pylori in gastrointestinal disease: implications for primary care of a revolution in management of dyspepsia.
Delaney BC
Br J Gen Pract; 1995 Sep; 45(398):489-94. PubMed ID: 7546874
[TBL] [Abstract][Full Text] [Related]
30. Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial.
van Marrewijk CJ; Mujakovic S; Fransen GA; Numans ME; de Wit NJ; Muris JW; van Oijen MG; Jansen JB; Grobbee DE; Knottnerus JA; Laheij RJ
Lancet; 2009 Jan; 373(9659):215-25. PubMed ID: 19150702
[TBL] [Abstract][Full Text] [Related]
31. [Indications for anti-ulcer drugs in adults].
Chassany O
Presse Med; 2000 Jan; 29(2):94-7. PubMed ID: 10682038
[No Abstract] [Full Text] [Related]
32. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
Hepatogastroenterology; 2005; 52(65):1617-21. PubMed ID: 16201128
[TBL] [Abstract][Full Text] [Related]
33. Symptomatic treatment and H. pylori eradication therapy for nonulcer dyspepsia.
Smucny J
Am Fam Physician; 2001 Nov; 64(9):1605-8. PubMed ID: 11730316
[No Abstract] [Full Text] [Related]
34. Dyspepsia and reflux in primary care: rough DIAMOND of a trial.
van Zanten SV
Lancet; 2009 Jan; 373(9659):187-8. PubMed ID: 19150689
[No Abstract] [Full Text] [Related]
35. Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
Bojarski C; Epple HJ; Kirstein FW; Fromm M; Bisson S; Riecken EO; Schulzke JD
Z Gastroenterol; 2000 Mar; 38(3):211-9. PubMed ID: 10768243
[TBL] [Abstract][Full Text] [Related]
36. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
37. Proton pump inhibitors for dyspepsia.
Vakil N
Dig Dis; 2008; 26(3):215-7. PubMed ID: 18463438
[TBL] [Abstract][Full Text] [Related]
38. [Functional dyspepsia: definition, classification, clinical and therapeutic management].
Montalto M; Santoro L; Vastola M; Curigliano V; Cammarota G; Manna R; Gasbarrini G
Ann Ital Med Int; 2004; 19(2):84-9. PubMed ID: 15317268
[TBL] [Abstract][Full Text] [Related]
39. [Helicobacter pylori infection in patients with functional dyspepsia, eradication rates in the Donetsk region].
Dorofeev AÉ; Rudenko NN; Agibalov AN; Kugler TE; Sibilev AV; Tomash OV
Lik Sprava; 2014 Nov; (11):119-22. PubMed ID: 25528848
[TBL] [Abstract][Full Text] [Related]
40. Proton pump inhibitors therapy vs H2 receptor antagonists therapy for upper gastrointestinal bleeding after endoscopy: A meta-analysis.
Zhang YS; Li Q; He BS; Liu R; Li ZJ
World J Gastroenterol; 2015 May; 21(20):6341-51. PubMed ID: 26034370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
